Abstract
A number of studies show that atrial natriuretic peptide (ANP) raises renal sodium excretion with a concomitant increase in glomerular filtration rate (GFR) in both experimental animals and normal humans. Studies using indirect evaluation of GFR have provided less consistent results in hypertensive patients. We studied the effects of intravenously administered (iv) α-human ANP on GFR in patients with hypertension by a radionuclide technique using technetium 99m diethylenetriaminepenta-acetic acid. In six patients (ANP group), GFR was determined under control conditions, during iv ANP (initial bolus of 0.5 μg/kg followed by a 21-min maintenance infusion at 0.05 μg · kg−1 · min−1) and during a recovery phase. In six other patients (control group), GFR was determined under control conditions, during saline iv infusion and during recovery. The two groups did not differ with respect to age, sex, basal blood pressure, heart rate or GFR. In the ANP group, the infusion of the peptide induced a significant decrease of mean blood pressure (from 133 ± 5 to 120 ± 5 mmHg, P < 0.01), no change in heart rate and a significant increase in GFR (from 104 ± 4 to 125 ± 5 ml/min, P < 0.01). During recovery, blood pressure, heart rate and GFR were not different from the values recorded under control conditions. No changes in blood pressure, heart rate or GFR (from 106 ± 5 to 108 ± 5 ml/min, n.s.) were detected during saline infusion in the control group. Our results demonstrated that in patients with essential hypertension, ANP induces an augmentation in GFR in spite of a decrease in blood pressure; this suggests a unique role for atrial peptide-related drugs in the treatment of human hypertension.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Beaseley D, Malvin L (1985) Atrial extracts increase glomerular filtration rate in vivo. Am J Physiol 248:1724–1730
Borenstein HP, Cupples WA, Sonnenberg H, Veress AT (1983) The effect of a natriuretic atrial extract on renal hemodynamics and urinary excretion in anesthetized rats. J Physiol 334:133–140
Briggs JP, Steipe B, Shubert G, Schnermann J (1982) Micropuncture studies of renal effects of atrial natriuretic substance. Pflügers Arch 395:271–276
Brochner-Mortensen J (1978) Routine methods and their reliability for assessment of glomerular filtration rate. Dan Med Bull 25:181–202
Camargo MJF, Kleinert HD, Atlas SA, Sealey JE, Laragh JH, Maack T (1984) Ca-dependent hemodynamic and natriuretic effects of atrial extract in isolated rat kidney. Am J Physiol 246:17447–17456
Chachati A, Meyers A, Godon JP, Rigo P (1987) Rapid method for the measurement of differential renal function: validation. J Nucl Med 28:829–836
Cody RJ, Atlas SA, Laragh JH, Kubo SH, Covit AB, Ryman KS, Sha Knovich A, Pandolfino K, Clark M, Camargo MJF, Scarborough RM (1986) Atrial natriuretic factor in normal subjects and heart failure patients: plasma levels and renal hormonal and hemodynamic responses to peptide infusion. J Clin Invest 78:1362–1374
Cogan MG (1986) Atrial natriuretic factor can increase renal solute excretion primarily by raising glomerular filtration. Am J Physiol 250:F710-F714
Cuocolo A, Esposito S, Volpe M, Celentano L, Brunetti A, Salvatore M (1989) Renal artery stenosis detection by combined Gates' technique and captopril test in hypertensive patients. J Nucl Med 30:51–56
DeBold AJ, Borenstein HB,Veress AT, Sonnenberg H (1981) A rapid and potent natriuretic response to intravenous injection of atrial myocardial extracts in rats. Life Sci 28:84–91
Fried TA, McCoy RN, Osgood RW, Reineck HJ, Stein J (1985) The effect of atrial natriuretic peptide on glomerular hemodynamics [abstract]. Clin Res 33:584
Gates GF (1982) Glomerular filtration rate: estimation from fractional renal accumulation of 99mTc DTPA (stannous) Am J Roentgenol 138:565–570
Ginjaume M, Casey M, Barker F, Duffy G (1985) Measurement of glomerular filtration rate using technetium-99m DTPA. J Nucl Med 26:1347–1348
Hirata Y, Ishii M, Sugimoto T, Matsuoka H, Fukui K, Sugimoto T, Yamakado M, Tagawa H, Miyata A, Kangawa K, Matsuo H (1988) Hormonal and renal effects of atrial natriuretic peptide in patients with secondary hypertension. Circulation 78:1401–1410
Huang CL, Lewicki J, Johnson LK, Cogan MG (1985) Renal mechanism of action of rat atrial natriuretic factor. J Clin Invest 75:766–773
Ichikawa I, Dunn BR, Troy JL, Maack T, Brenner BM (1985) Influence of atrial natriuretic peptide on glomerular microcirculation in vivo [abstract]. Clin Res 33:487
Keeler R (1982) Atrial natriuretic factor has a direct prostaglandin-independent action on kidneys. Can J Physiol Pharmacol 60:1078–1082
Kleinert HD, Volpe M, Odell G, Mazion D, Atlas SA, Camargo MJF, Laragh JH, Maack T (1986) Cardiovascular effects of synthetic atrial natriuretic factor in anesthetized and conscious dogs. Hypertension 8:312–316
Kopecky RT, Thomas FD, McAfee JG (1987) Furosemide augments the effects of captopril on nuclear studies in renovascular stenosis. Hypertension 10:181–188
McAfee JG, Kopecky RT, Thomas FD, Hellwig B, Roskopf M (1988) Comparison of different radioactive agents for the detection of renovascular hypertension with captopril in a rat model. J Nucl Med 29:509–515
McKenzie JK, Clements SA (1974) Simplified radioimmunoassay for serum aldosterone utilizing increased antibody specificity. J Clin Endocrinol Metab 36:622–630
Menard J, Catt KJ (1972) Measurements of renin activity by radioimmunoassay of angiotensin I. Endocrinology 90:422–429
Schlegel JU, Halikiopoulos HL, Prima R (1979) Determination of filtration fraction using the gamma scintillation camera. J Urol 122:447–450
Tikkanen I, Fyhrquist R, Metsarinne K, Leidenius R (1985) Plasma atrial natriuretic peptide in cardiac and during infusion in healthy volunteers. Lancet I:66–69
Tonnesen KH, Munck O, Hald T, Mogensen P, Wolf H (1975) Influence on the renogram of variation on skin to kidney distance and the clinical importance thereof. In: Zum Winkel K, Blaufox MD, Bretano JLF (eds) Radionuclides in nephrology. Thieme, Stuttgart, pp 79–86
Vander AJ (1967) Control of renin release. Physiol Rev 47:359–382
Volpe M, Odell G, Kleinert HD, Müller F, Camargo MJ, Lazagh JH, Maack T, Vaughan ED, Atlas SA (1985) Effect of atrial natriuretic factor on blood pressure, renin and aldosterone in Goldblatt hypertension. Hypertension 7 [Suppl 1]:43–48
Volpe M, Cuocolo A, Vecchione F, Mele AF, Condorelli M, Trimarco B (1987) Vagal mediation of the effects of atrial natriuretic factor (ANF) on blood pressure and arterial baroreflexes in the rabbit. Circ Res 60:747–755
Volpe M, De Luca N, Cappelli Bigazzi M, Vecchione F, Lembo G, Condorelli M, Trimarco B (1988) Atrial natriuretic factor potentiates forearm reflex-vasoconstriction induced by cardiopulmonary receptor deactivation in man. Circulation 77:849–855
Weder AB, Sekkarie MA, Takiyyuddin M, Schork N, Julius S (1987) Antihypertensive and hypotensive effects of atrial natriuretic factor in men. Hypertension 10:582–589
Weidmann P, Hasler L, Gnadinger MP, Lang RE, Uehlinger DE, Shaw S, Rascher W, Reubi FC (1986) Blood levels and renal effects of atrial natriuretic peptide in normal men. J Clin Invest 77:734–742
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Cuocolo, A., Volpe, M., Melee, A.F. et al. Effects of atrial natriuretic peptide on glomerular filtration rate in essential hypertension: a radionuclide study. Eur J Nucl Med 18, 32–37 (1991). https://doi.org/10.1007/BF00177682
Received:
Revised:
Issue Date:
DOI: https://doi.org/10.1007/BF00177682